Predictors and 3-year outcomes of compromised left circumflex coronary artery after left main crossover stenting

Hameed Ullah1, Karim Elakabawi1,2, Han Ke1

  • 1Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Clinical Cardiology
|July 16, 2021
PubMed

Insights

Fractional flow reserve (FFR) guided intervention can help avoid unnecessary procedures in the left circumflex coronary artery (LCx) after left main (LM) stenting. Key predictors of low FFR include post-stenting minimal luminal area and plaque burden in the LCx.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Imaging
  • Clinical Outcomes Research

Background:

  • Predictors for reduced fractional flow reserve (FFR) in the left circumflex coronary artery (LCx) following left main (LM) crossover stenting are not well-established.
  • Understanding these predictors is crucial for optimizing treatment strategies and patient outcomes.

Purpose of the Study:

  • To identify predictors of low FFR in the LCx post-LM stenting.
  • To evaluate treatment strategies for compromised LCx and their long-term outcomes.

Main Methods:

  • A cohort of 563 patients with significant distal LM bifurcation lesions underwent single-stent crossover percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS).
  • LCx intervention decisions were based on measured FFR.
  • Long-term outcomes, including major adverse cardiac events (MACE), were assessed over three years.

Main Results:

  • Only 20.6% of patients had an FFR < 0.8 in the LCx despite angiographic evidence of ostial affection.
  • Low LCx FFR was significantly associated with post-stenting minimal luminal area (MLA) of LCx, LCx plaque burden, post-stenting LM MLA, and pre-stenting LCx MLA.
  • In patients with low FFR, treatment with a drug-eluting balloon resulted in the lowest three-year MACE rate (8.1%) compared to kissing balloon inflation (17.5%) or stenting (20.5%).

Conclusions:

  • FFR-guided intervention can prevent unnecessary LCx procedures after LM stenting.
  • Post-stenting MLA and plaque burden of the LCx, along with main vessel stent length, are significant predictors of low FFR.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
55
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
77
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
287
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
93
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
117
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
426